文献速递新发突发、热带与寄生虫病医院感染防控

塞拉利昂埃博拉与疟疾共感染患者的特征与生存分析

Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study.
PubMed 文献 · Lancet Infect Dis · 2017-03-01

该回顾性队列研究分析了塞拉利昂三家埃博拉治疗单元收治的1524例疑似埃博拉患者,其中1368例有疟疾和埃博拉诊断数据。结果显示埃博拉阴性患者中33%疟疾阳性,埃博拉阳性患者中21%合并疟疾;

要点

  • 埃博拉治疗单元中疟疾共感染常见,埃博拉阳性者21%合并疟疾。
  • 埃博拉合并疟疾患者死亡率66%,死亡风险显著高于无感染者。
  • 无埃博拉也无疟疾者死亡率也较高,提示需扩大检测和治疗。

核心结论

  • 疟疾共感染在埃博拉治疗单元患者中常见,并增加埃博拉患者死亡风险,支持经验性疟疾治疗。
  • 无埃博拉也无疟疾的患者死亡率高,提示扩大检测和治疗可能改善未来埃博拉疫情中的诊疗。

研究设计与样本

  • 埃博拉检测采用实时PCR,疟疾检测采用快速诊断试验。

主要发现

  • 1368例有诊断数据的患者中,1114例埃博拉阴性,其中365例(33%)疟疾阳性;254例埃博拉阳性,其中53例(21%)合并疟疾。
  • 埃博拉合并疟疾组死亡35/53(66%),单纯埃博拉组死亡105/201(52%)。

临床怎么用

  • 在埃博拉治疗单元中,对疑似埃博拉患者应考虑经验性疟疾治疗。
  • 对无埃博拉也无疟疾的患者,需扩大检测和治疗以改善预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The 2014-15 Ebola virus disease (EVD) epidemic strained health systems in west Africa already overburdened with other diseases, including malaria. Because EVD and malaria can be difficult to distinguish clinically, and rapid testing was not available in many Ebola Treatment Units (ETUs), guidelines recommended empirical malaria treatment. Little is known, however, about the prevalence and characteristics of patients entering an ETU who were infected with malaria parasites, either alone or concurrently with Ebola virus. METHODS: Data for sociodemographics, disease characteristics, and mortality were analysed for patients with suspected EVD admitted to three ETUs in Sierra Leone using a retrospective cohort design. Testing for Ebola virus was done by real-time PCR and for malaria by a rapid diagnostic test. Characteristics of patients were compared and survival analyses were done to evaluate the effect of infection status on mortality. FINDINGS: Between Dec 1, 2014, and Oct 15, 2015, 1524 cases were treated at the three ETUs for suspected EVD, of whom 1368 (90%) had diagnostic data for malaria and EVD. Median age of patients was 29 years (IQR 20-44) and 715 (52%) were men. 1114 patients were EVD negative, of whom 365 (33%) tested positive for malaria. Of 254 EVD positive patients, 53 (21%) also tested positive for malaria. Mortality risk was highest in patients diagnosed with both EVD and malaria (35 [66%] of 53 died) and patients diagnosed with EVD alone (105 [52%] of 201 died). Compared with patients presenting to ETUs without malaria or EVD, mortality was increased in the malaria positive and EVD positive group (adjusted hazard ratio 9·36, 95% CI 6·18-14·18, p<0·0001), and the malaria negative and EVD positive group (5·97, 4·44-8·02, p<0·0001), but reduced in the malaria positive and EVD negative group (0·37, 0·20-1·23, p=0·0010). INTERPRETATION: Malaria parasite co-infection was common in patients presenting to ETUs and conferred an increased mortality risk in patients infected with Ebola virus, supporting empirical malaria treatment in ETUs. The high mortality among patients without EVD or malaria suggests expanded testing and treatment might improve care in future EVD epidemics. FUNDING: International Medical Corps.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Waxman M, Aluisio AR, Rege S, et al. Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study. Lancet Infect Dis. 2017. PMID: 28258817. doi:10.1016/S1473-3099(17)30112-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。